Programme

Day 1 – Friday 15 February 2019

14:00   Welcome

14:15   Keynote lecture: Microbiome and Immune System in Cancer
Laurence Zitvogel (Gustave Roussy, France)

14:50   Impact of the microbiome during adulthood

15:10   Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation

15:30   Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery

15:50   COFFEE BREAK

16:30   Potential of fecal microbiota for early-stage detection of colorectal cancer
Georg Zeller (EMBL Heidelberg, Germany)

16:50   Crosstalk of the microbiome and epithelial cells
Dirk Haller, (Technische Universität München, Germany)

17:10   Diet and the microbiome – Lessons from twin studies

17:30   Gut microbiota-derived propionate reduces cancer cell proliferation in the liver
Laura Bindels (Université Catholique de Louvain, BE)

END OF DAY 1

19:30   Networking Event in Munich

Day 2 – Saturday 16 February 2019

09:30   Keynote lecture: Microbiome & Immunotherapy in Cancer
Giorgio Trinchieri (Center for Cancer Research/NCI/NIH, USA)

10:05   Interplay of innate lymphoid cells and the microbiota
Andreas Diefenbach (Charité – Universitätsmedizin Berlin, Germany)

10:25  Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment
Andrea Botticelli (Sant´Andrea Hospital, Italy)

10:45   COFFEE BREAK

11:15   The Intra-tumoral bacterial flora – potential implications
Mark Tangney (University College Cork, Ireland)

11:35   The effect of tumor & gut microbiome on drug resistance  

11:55   Microbiota-based supplements – the future of cancer treatment?
Maria Vehreschild (University Hospital Cologne, DE)

12:15   Challenges in Regulating Microbiota
Anja Düchting (BfArM, DE)

CLOSING REMARKS

12:35   Concluding remarks and discussion

13:00   END OF THE MEETING